Diabetes

Showing NaN - NaN of 87

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Developing Enhanced Prediction Models

Completed
  • Acute Myocardial Infraction or Chest Pain
  • +4 more
    • Philadelphia, Pennsylvania
      Penn Medicine
    Feb 5, 2020

    Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of

    Completed
    • Acute Ischemic Stroke
    • +2 more
    • IV insulin to maintain target glucose concentration of 80-130 mg/dL
    • Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
    • Tucson, Arizona
    • +69 more
    Dec 13, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tuscumbia, Alabama
    • +208 more
    Oct 2, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec
    • insulin glargine
    • Birmingham, Alabama
    • +445 more
    Jul 10, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Alabaster, Alabama
    • +427 more
    Jul 3, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +252 more
    Jun 20, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec
    • +2 more
    • Little Rock, Arkansas
    • +80 more
    Jun 3, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +230 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Mobile, Alabama
    • +190 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Tucson, Arizona
    • +151 more
    May 28, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Phoenix, Arizona
    • +98 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec/insulin aspart
    • +2 more
    • Phoenix, Arizona
    • +72 more
    Jun 3, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Phoenix, Arizona
    • +154 more
    May 22, 2019

    Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec
    • insulin glargine
    • Birmingham, Alabama
    • +165 more
    Apr 30, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Concord, California
    • +96 more
    Mar 6, 2019

    Diabetes, Cardiovascular Disease Trial in Philadelphia (Process Incentive, Outcome Incentive)

    Completed
    • Diabetes
    • Cardiovascular Disease
    • Process Incentive
    • Outcome Incentive
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Feb 25, 2019

    HIV, Cardiovascular Disease, Diabetes Trial in Philadelphia (Health Promotion Intervention, Health Awareness Control

    Completed
    • HIV
    • +4 more
    • Health Promotion Intervention
    • Health Awareness Control Intervention
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Feb 4, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • insulin glargine
    • Fresno, California
    • +90 more
    Dec 7, 2018

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • insulin degludec
    • Huntsville, Alabama
    • +85 more
    Dec 7, 2018

    Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec
    • +2 more
    • Birmingham, Alabama
    • +98 more
    Dec 7, 2018

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Insulin NPH, Diet/exercise)

    Terminated
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Insulin detemir
    • +2 more
    • Tucson, Arizona
    • +81 more
    Aug 9, 2018

    Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (insulin aspart, inhaled human insulin)

    Terminated
    • Diabetes
    • +3 more
    • insulin aspart
    • inhaled human insulin
    • Fresno, California
    • +31 more
    Sep 3, 2018

    Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)

    Terminated
    • Diabetes
    • Diabetes Mellitus, Type 1
    • inhaled human insulin
    • +2 more
    • Birmingham, Alabama
    • +95 more
    Sep 3, 2018

    Diabetes, Cardiovascular Disease Trial in Philadelphia (Twitter Diabetes Intervention)

    Completed
    • Diabetes
    • Cardiovascular Disease
    • Twitter Diabetes Intervention
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 31, 2018

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • +2 more
    • Tuscumbia, Alabama
    • +116 more
    Mar 1, 2018